‹ ›
MYP_142445
← PREVIOUS NEXT → BACK
Basic Information
EB-Lytic
Anticancer
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
32 amino acids
C183H301N45O39
Standard
Sequence
YHWYGYTPQNVIGGGKLLLKLLKKLLKLLKKK
Physicochemical Analysis
3755.63 Da
10.24
7.84
7.57
0.2449
-0.23
0.84
0.05
-5.46
130.94
0.1250
9970.00
9970.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1376.36
-3.34
48.0
48.0
131.0
267.0
7.0
33.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0317095 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
None
None
Bio-Activity Profile
Anticancer Cytotoxic
BxPC-3
12 μM
IC50
PaperSelective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide Evidence URLhttps://patents.google.com/patent/US8436137B2/en PatentUS8436137B2
RECORD: Rec_0331391 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
None
None
Bio-Activity Profile
Anticancer
H-322
6.8 μM
IC50
PaperSelective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide Evidence URLhttps://patents.google.com/patent/US8436137B2/en PatentUS8436137B2
RECORD: Rec_0332579 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
None
None
Bio-Activity Profile
Anticancer
SU.86.86
12 μM
IC50
PaperSelective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide Evidence URLhttps://patents.google.com/patent/US8436137B2/en PatentUS8436137B2
RECORD: Rec_0341938 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
None
None
Bio-Activity Profile
Antimicrobial Anticancer
MDA-MB-231
0.46 μM
IC50
PaperPubMed PMID: 21351323 PMID21351323 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21351323/
RECORD: Rec_0398439 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
None
None
Bio-Activity Profile
Anticancer
BT-20
6.5 μM
IC50
PaperSelective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide Evidence URLhttps://patents.google.com/patent/US8436137B2/en PatentUS8436137B2
FIRST PREV 1 2 3
Showing 5 records on this page · Page 3 of 3